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Abstract - PURPOSE To explore the frequency of 
polypharmacy, functional and cognitive capacity among 
the elderly in Southern Italy. METHODS Population-
based retrospective cross-sectional study. Information 
were retrieved from electronic-geriatric-forms matched by 
record-linkage to outpatient pharmacy-records. The 
following domains were collected from geriatric forms: 
BMI, cognitive capacity (SPMSQ), functional status 
(Barthel-index), mobility, living condition. Polypharmacy 
status was categorized as non-polypharmacy (0-4), 
polypharmacy (5-9) and excessive-polypharmacy (>10). 
Prevalence of all variables were stratified by age and 
polypharmacy group. RESULTS 88,878 old people 
received a geriatric assessment in the years 2013-2014. 
Mean age was 74.8 (±7.3) years, 56.6% females. 
Proportion of elderly in excessive-polypharmacy 
increased with age (18.9% in 65-75 age-group; 27.9% in 
>85). Referring to cognitive capacity, the proportion of 
lucid patients decreased with age (from 94.3% to 58.1%), 
while confused patient increased with age (from 4.7% to 
30.9%). Proportion of subjects with a decline in cognitive 
status, functional status and mobility increased in 
polypharmacy and excessive polypharmacy group. 
CONCLUSION Polypharmacy is common in people aged 
65 years and older with difficulties in activities of daily 
living and impaired cognition. Furthermore, its prevalence 
raises with increasing age. Preventive strategies such us 
optimization of drug regimen should be performed 
routinely to reduce risk of adverse-health-events. 
 
Key words: Polypharmacy, elderly, administrative 
databases, frailty, geriatric assessment. 
 
I.  INTRODUCTION 
 
 Polypharmacy is one of the most relevant health-
related issues in elderly population.  Drug treatment may 
influence both positively and negatively elderly health 
status.  Polypharmacy increases the risk of inappropriate 
prescribing, drug–drug and drug–disease interactions, and 
hence the risk of adverse health events including falls, 
functional impairment, and hospitalization [1-2]. 
 Nowadays, different sets of indicators have been 
developed in order to provide a measure of prescribing 
performance and, hence, to assess quality of care in older 
people [3-4]. However, this may not be sufficient for frail 
elderly who have several problems related to the 
functional status, mobility, cognitive status and living 
condition.  In these patients, the most appropriate 
approach to re-evaluate the drug- therapy should combine 
evidence-based data with information gathered from a 
multidimensional geriatric assessment. Recently, 
Multidimensional Assessment Schedule (SVaMA) was 
developed to effectively explore multiple domains of 
health, as multidimensional and multidisciplinary tool of 
choice to determine the prognosis of the functionally 
compromised and frail older subject [5]. SVaMa includes 
information on functional (activities of daily living, ADL, 
and Instrumental ADL), cognitive status (Short Portable 
Mental Status Questionnaire), nutrition (Mini Nutritional 
Assessment), comorbidities (Cumulative Illness Rating 
Scale), medications and co-habitation status (i.e. living 
alone or with someone).  
In 2012 the European Commission launched an initiative 
called ‘European Innovation Partnership on Active and 
Healthy Aging’ (EIP-AHA) with the purpose of 
stimulating research and innovation in EU and increase 
understanding around frailty and the prevention, early 
diagnosis and management of functional decline, both 
physical and cognitive, in older people [6].  
Since 2013 Campania Regional Health-Care System 
introduced electronic geriatric forms available to general 
practitioners to perform a multidimensional assessment on 
community-dwelling older patients. The aim of this 
population-based retrospective study was to explore the 
frequency of polypharmacy and the functional status of 
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older outpatients from Caserta Local Health Unit (LHU), 




Study design: we designed a retrospective cross-sectional 
study. 
Setting: electronic geriatric forms from the Local Health 
Authority (LHU) of Caserta in the Campania Region 
(Southern Italy), covering a population of about 1,000,000 
inhabitants.  
Data sources 
The data used for this study were obtained from electronic 
geriatric forms in the SANIARP Portal, a web platform 
available to general practitioners (GPs) of LHU Caserta, 
collected from January 1, 2013 to December 31, 2014 
(study period). Electronic geriatric card was a short 
version of SVaMA. The SVaMA is the officially 
recommended assessment schedule used by the health 
personnel of the National Health Care System to perform 
a multidimensional assessment on community-dwelling 
older persons or nursing home residents to establish 
accessibility to some health care resources [5]. From the 
electronic geriatric cards the following information were 
obtained: Body Mass Index (BMI); cognitive capacity 
(Short Portable mental Status Questionnaire SPMSQ); 
functional status (Barthel index); mobility (Barthel index), 
living condition and senses and communication skills 
(language understanding, language production, hearing 
and sight). This data source was matched, by record-
linkage analysis to outpatient pharmacy records and the 
civil registry in order to collect pharmaceutical 
information (number of drugs) and demographic 
information (i.e. age, gender, date of death or emigration) 
of all residents covered by the LHU. All information was 
linked through a unique and anonymous personal 
identification code. As this automated system is 
anonymous, neither ethical committee approval nor 
informed consent was required. Furthermore, the 
anonymous data file is routinely used by the local health 
authority for epidemiological and administrative purposes. 
Permission to use it for the present study was granted by 
the responsible authority. The reliability of this strategy to 
produce pharmacoepidemiological information has been 
previously documented [7-8].  
 
Study population  
The study population consisted of all subjects of 65 years 
of age or older who had at least one geriatric assessment 
form during the study period (January, 1 2013 to 
December, 31 2014). We considered the latest form for 
patients with more than one geriatric assessment. Age was 




Short Portable mental Status Questionnaire SPMSQ is a 
short questionnaire that is used to screen older adults for 
dementia signs and other neurologically based deficits and 
to determine the degree of impairment [9]. 
Functional status was evaluate by Barthel scale or 
Barthel Index. This is an ordinal scale used to measure 
performance in activities of daily living (ADL). Each 
performance item is rated on this scale with given number 
of points assigned to each level or ranking [10]. The rating 
scale autonomy in basic activities of daily living proposal 
by Katz et al. is one of the tools used in the evaluation of 
geriatric patient [11]. The tool evaluates accurately basic 
tasks: to bathe, dressing up, toilet, move, urinary and fecal 
incontinence, feed themselves. The index measures the 
different abilities of the patient in taking care of 
themselves and each is measured in terms of what the 
patient is functional or not. To each of the items goes 
given a score dichotomous in which: 0 = dependent 1 = 
independent  
Mobility was assessed by four tasks: Transfer bed / chair, 
walk, use of wheelchair, use the stairs. Each performance 
item is rated on the Barthel index. To each of the items 
goes given a score dichotomous in which: 1 = moves by 
self’s 2= assisted [12].  
Living condition was determined on the basis of living 
condition at the time of examination. Living status was 
coded for those participants living alone or with someone. 
(Alone = 1; with someone = 2) [13].  
Language (understanding and production) was 
categorized into 3 groups: Normal, Understand only 
simple sentences or disorder of language, doesn't 
understand doesn't speak respectively.  
Hearing and Sight was categorized into 4 groups: 
Normal, Serious deficit, Serious deficit incurable and 
finally deafness or blindness. 
Polypharmacy was defined as a three-class variable: 
excessive polypharmacy defined as the use of ten or more 
drugs; polypharmacy as the use of five to nine drugs; non-
polypharmacy as the use of four or less drugs 
concomitantly [14]. 
Prevalence of all variables were stratified by age-group 
(65-75 years; 75-84 years; >85 years) and polypharmacy 




Characteristics of the study population were analysed 
using descriptive statistics: quantitative variables were 
described by means and standard deviations while 
categorical variables were described by counts and 
percentages. In the case of categorical variables, cross-
tabulations with chi-square tests were used for comparing 
the differences between age group and polypharmacy 
group. All analyses were performed using SPSS software 
version 17.1 for Windows (SPSS Inc., Chicago, IL, USA). 
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III. RESULTS 
 
A total of about 90,000 elderly were analysed in this 
study. This amount represents more than 60% of the total 
elderly population in LHU Caserta. The mean patient age 
at the index date was 74.8 (±7.3) years with 53.7% of the 
patients between 65-74 years of age, 34.6% of the patients 
between 75-84 years of age, 11.7% of patients 85 of age 
or more.  Baseline characteristics of the study population 
are shown in Table 1. 56.6% of patients were women. The 
mean BMI of patients was 27.0 (± 4.0). In particular, 
percentage of overweight elderly decreased from 43.0% in 
subjects aged 65-74 years to 35.8% in subjects aged 85 or 
more. Proportion of elderly in polypharmacy increased 
from 42.7% in subject aged 65-74 years to 45.4% in 
subject aged 85 or more. More in detail, with regard to 
excessive polypharmacy, there was a slightly increase 
from 18.9% in subject aged 65-74 years to 27.9% in  
subject aged 85 or more. Referring to cognitive capacity, 
the proportion of confused patients increased from 4.7% 
in patients aged 65-74 years to 30.9% in patients aged 85 
or more. The percentage of very confused patients 
increased from 0.9% in patients aged 65-74 years to 
11.0% in patients aged 85 or more.  In the matter of 
functional status, the percentage of patients dependent in 
their activities of daily living rose from 2.9% in patients 
aged 65-74 years to 36.2% in patients aged 85 or more.  
Therefore, about mobility, the proportion of elderly 
needing help to move increased from 5.3% in subject aged 
65-74 years to 48.7% in subject aged 85 or more. Overall, 
87.5% of elderly living with someone and only 12.5% 
living alone. Regarding senses and communication skills, 
the proportion of elderly having problems with language, 
hearing and sight increased proportionally with the age. In 
particular, the percentage of elderly who “understand only 
simple sentences” and “disorder of language” increased 
from 6.7% and 9.0% in subject aged 75-84 years to 17.6% 
and 22.4% in subject aged 85 or more, respectively. 
Therefore, referring to hearing and sight the percentage of 
elderly with serious deficit increased from 17.8% and 
29.2% in subject aged 65-74 years to 58.3 and 62.2% in 
subject aged 85 or more, respectively.  
Approximately 67.4% of elderly are treated with five or 
more drugs. In particular, the proportion of elderly 
patients in polypharmacy, defined as the use of five to 
nine drugs, was 44.2% and 23.2% was in excessive 
polypharmacy, defined as the use of more than ten drugs, 
as shown in Table 2. Proportion of subjects with a decline 
in cognitive status, functional status and mobility 
increased in polypharmacy and excessive polypharmacy 
group. Referring to SPMSQ score, the percentage of 
confused patients increased from 8.0% in non-
polypharmacy group to 15.6% in excessive polypharmacy 
group.  The percentage of very confused patient rose from 
2.3% in non-polypharmacy group to 4.4% in excessive 
polypharmacy group. The same trend in proportion 
occurred for functional status and mobility. In particular, 
the proportion of elderly dependents increased in all three 
groups of polytherapy (5.4%; 9.1%; 17.0% respectively).  
The percentage of elderly assisted increased from 8.3% in 
non-polypharmacy group to 25.6% in excessive 
polypharmacy group.  
 
Table 1. Baseline characteristics of the study population 
Variables 
 































































































































































Functional status (Barthel Index) <0.001 
 



















Mobility (Barthel Index) <0.001 
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Language (production) <0.001 
 









































































































Table 2. Mobility, functional status and cognitive status (N, %) 





















































 Functional status (Barthel Index) <0.001 
  















 Mobility (Barthel Index) <0.001 
  






















This population-based study investigated the 
frailty status, assessed through multidimensional 
evaluation of different domains, in a large population of 
elderly outpatients by using electronic geriatric forms in 
the SANIARP portal, a web platform available to GPs of 
LHU Caserta. 
Overall, the study showed that polypharmacy status was 
very frequent in our population, in detail about 44% of 
elderly patients received between five and nine drugs and 
23.2% took more than ten drugs. While the data regarding 
polypharmacy (5-9 drugs) are in line with findings from 
Italian National Agency (AIFA) [15], we found a higher 
percentage of elderly in excessive polypharmacy 23% vs 
11%. This could be due to the different data sources as we 
analysed not only drugs dispensed by community 
pharmacies but also drugs dispensed directly by hospital 
pharmacies. Furthermore underlying population and 
observation period of the analysis was different. Our 
findings are clinically relevant insofar as polypharmacy is 
associated with a higher risk of poor health outcomes such 
as falls, avoidable hospitalization [16-18]. Furthermore 
the excessive polypharmacy is associated with decline in 
nutritional status, functional ability and cognitive capacity 
in elderly persons aged 75 years and older [19]. Apart 
from polytherapy we also analysed decline in cognitive 
status, functional status and mobility. Our findings 
showed that subjects aged 85 or more 30.9% were 
confused, 36.2% were dependent, 48.7 % were assisted 
and about 20% had a disorder of language. All these 
conditions may affect aspects related to therapeutic 
appropriateness followed by the patient: our findings 
showed that about 28% of highest age category received 
more than nine drugs. A recent study conducted by Herr et 
al. estimated that each additional drug prescribed was 
associated with an increased risk of being pre-fail or 
dependent, with adjusted OR 1.12 (95% CI 1.07-1.17), 
1.20 (95% CI 1.12-1.128) and 1.26 (95% CI 1.17-1.35), 
respectively [20].  
The study evaluated only polypharmacy status but not 
wise use of drug therapy so we cannot state whether the 
27% of oldest old in polypharmacy is treated 
appropriately or not. However it must be kept into account 
that the coexistence of clinical complexity along with the 
lack of evidence on drug effectiveness from clinical trials 
in very old persons, does not provide physicians with 
knowledge on outcomes associated with an aggressive 
pharmacological treatment.  
In view of this evidence, preventive strategies should be 
devised for old people with regard to physical activity, 
cognitive status and management of chronic diseases. The 
optimization of polypharmacy is part of these actions. 
Different approaches to reduce unnecessary medication 
use in elderly have been considered, involving 
pharmacists or geriatricians, using implicit or explicit 
criteria. Nevertheless, research is still needed to determine 
the most efficient strategies [21-22].  
It is important to outline that there is a lack of 
consideration of the frail status in therapeutic guidelines 
although some age-related conditions may have an impact 
of late-life influencing, such as frailty [23].   
Frailty in older people reflects a nonspecific state of 
vulnerability and a multisystem physiological change with 
increased risk for adverse health outcomes in older age 
[24]. In fact, frailty is acknowledged to be a 
multidimensional concept associated with a greater risk 
for adverse health-related outcomes such as falls, 
disability, hospitalization, permanence institutionalization 
Translational Medicine @ UniSa - ISSN 2239-9747 2015, 13(9): 59-64
 
63 
Università degli Studi di Salerno 
and death [25].  Our study was limited to describe several 
domains that can influence frailty status. We did not 
define a score to assess this aspect. In fact available 
information are only a part of the complete SvaMa. 
However we described some of the conditions that should 
be considered in the evaluation and revision of therapy in 
elderly patients. 
It would be interesting to define frailty scores from our 
data in order to achieve a better use of patient information. 
The most recent evidences highlighted how it is possible 
to calculate, on the basis of validated algorithms, from 
SVAMA the Multidimensional Prognostic Index (MPI) 
able to predict the risk of mortality. The clear advantage 
of this instrument can result in a significant chance to 
reduce mortality, functional disability and cognitive 
impairment of older subjects, according to the most recent 
evidence in clinical geriatric practice [26-27].  
The strength of our study is that it was possible to match 
data coming from different sources (administrative 
database and electronic geriatric cards in the SANIARP 
Portal) at single patient level. In this way, we were able to 
collect information about the functional status, cognitive 
status and mobility according to drug prescription records, 
while keeping into account relevant personal details such 
as sex and age. On the other hand, information about the 
type of drugs taken by elderly patients and the presence of 
comorbidities were not investigated as the aim of this 
study was evaluate level of polypharmacy and excessive 
polypharmacy according to other domains relevant in the 
evaluation of drug therapy in the elderly such as 
functional, cognitive and mobility status. The present 
initiative is part of the strategy carried out by the EIP-
AHA A1 Action Group on adherence and provides 
preliminary data that might be useful for more focused 
interventions. Moreover it can represent a point of synergy 
with EIP-AHA A3 Action Group on frailty as 
polypharmacy has also great relevance in assessment of 
vulnerability of elderly patients. 
 
V.  CONCLUSION 
 
 Our study highlighted that polypharmacy is more 
frequent in older patients with a decline in cognitive 
status, functional status and mobility. All these conditions, 
associated with polypharmacy regimen can influence 
frailty status and can affect treatment outcomes with a 
greater risk for adverse health-related outcomes. Our 
findings emphasize how important are preventive 
strategies such as optimization of drug regimen for a 
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